BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 29023892)

  • 1. Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges.
    Nayak TK; Brechbiel MW
    Bioconjug Chem; 2009 May; 20(5):825-41. PubMed ID: 19125647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119.
    Randhawa P; Olson AP; Chen S; Gower-Fry KL; Hoehr C; Engle JW; Ramogida CF; Radchenko V
    Curr Radiopharm; 2021; 14(4):394-419. PubMed ID: 33430758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protocol for controlled reactivity shift in the 2,2-difluorovinyl motif used for selective S-
    Maqbool M; Jakobsson JE; Alluri SR; Kramer V; Riss PJ
    Commun Chem; 2024 Apr; 7(1):97. PubMed ID: 38684771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical radioguidance with beta-emitting radionuclides; challenges and possibilities: A position paper by the EANM.
    Fragoso Costa P; Shi K; Holm S; Vidal-Sicart S; Kracmerova T; Tosi G; Grimm J; Visvikis D; Knapp WH; Gnanasegaran G; van Leeuwen FWB
    Eur J Nucl Med Mol Imaging; 2024 Jan; ():. PubMed ID: 38189911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemistry for Positron Emission Tomography: Recent Advances in
    Deng X; Rong J; Wang L; Vasdev N; Zhang L; Josephson L; Liang SH
    Angew Chem Int Ed Engl; 2019 Feb; 58(9):2580-2605. PubMed ID: 30054961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of radionuclides and radiochemical impurities produced by in-house cyclotron irradiation and subsequent radiosynthesis of PET tracers.
    Ishiwata K; Hayashi K; Sakai M; Kawauchi S; Hasegawa H; Toyohara J
    Ann Nucl Med; 2017 Jan; 31(1):84-92. PubMed ID: 27744544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography.
    Dollé F
    J Labelled Comp Radiopharm; 2013; 56(3-4):65-7. PubMed ID: 24285311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding PET-applications in life sciences with positron-emitters beyond fluorine-18.
    Coenen HH; Ermert J
    Nucl Med Biol; 2021 Jan; 92():241-269. PubMed ID: 32900582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclotrons and positron emission tomography radiopharmaceuticals for clinical imaging.
    Saha GB; MacIntyre WJ; Go RT
    Semin Nucl Med; 1992 Jul; 22(3):150-61. PubMed ID: 1523413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Labelling with positron emitters of pnicogens and chalcogens.
    Ermert J
    J Labelled Comp Radiopharm; 2018 Mar; 61(3):179-195. PubMed ID: 29023892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocatalysis in radiochemistry: Enzymatic incorporation of PET radionuclides into molecules of biomedical interest.
    da Silva ES; Gómez-Vallejo V; López-Gallego F; Llop J
    J Labelled Comp Radiopharm; 2018 Apr; 61(4):332-354. PubMed ID: 29231247
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.